Skip to main content
Clinical Trials/JPRN-UMIN000009078
JPRN-UMIN000009078
Completed
Phase 2

Clinical trial of postoperative IMRT (intensity modulated radiotherapy) for cervical cancer with high risk factors for relapse. - Clinical trial of postoperative IMRT (intensity modulated radiotherapy) for cervical cancer with high risk factors for relapse.

ational Cancer Center Hospital, Tokyo, Japan.0 sites25 target enrollmentOctober 10, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Postoperative cervical cancer patients with high risk factors for relapse
Sponsor
ational Cancer Center Hospital, Tokyo, Japan.
Enrollment
25
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2012
End Date
October 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
ational Cancer Center Hospital, Tokyo, Japan.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with DM using continuous insulin or DM of poor control. 2\) Patients with hypertension of poor control. 3\) Patients with unstable angina or with myocardial infarction last 6 months. 4\) Patients with active concomitant malignancy. 5\) Patients with active infection requiring systemic therapy. 6\) Pelvic infection of more than grade 3\. 7\) Patients with fever more than 38\.0 degrees C at the registration. 8\) Patients with psychological problems and inappropriate for entering this study. 9\) Patients with ulcerative colitis or Crohn disease. 10\) Patients with collagen disease such as SLE or scleroderma.

Outcomes

Primary Outcomes

Not specified

Similar Trials